GlassScriptPhysician profile
Shailja Mehta
NPI 1578982880
$2,386.88
in general payments reported to CMS, 2019-2025
9 companies · $1,570 in 2025
The $1,570 reported for 2025 was more than what 79% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.66 · 2022: $310 · 2023: $28.88 · 2024: $386 · 2025: $1,570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,425 · Food and Beverage: $530 · Gift: $28.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,425.00 |
| Food and Beverage | $530.39 |
| Gift | $28.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,603.03 | 2024-2025 | |
| Boston Scientific Corporation | $304.53 | 2022-2024 | |
| Medtronic, INC. | $173.88 | 2022 | |
| Axonics, INC. | $128.02 | 2024 | Axonics |
| Coloplast Corp | $63.68 | 2021 | |
| Bluewind Medical | $30.88 | 2025 | Revi |
| Intuitive Surgical, INC. | $28.98 | 2021 | |
| Caldera Medical, INC | $28.88 | 2023 | Desara |
| Femselect INC. | $25.00 | 2024 | Enplace |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shailja Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.